Id: A-D1-P-C1-Composition
Identifier: urn:ietf:rfc:3986#urn:uuid:b505b90a-f241-41ca-859a-b55a6103e753
Status: Final
Code: Immunization record (http://snomed.info/sct#41000179103)
Patient: Patient/TC-patient Wegmueller Monika
Date: June 1, 2021
Authors:
Patient/TC-patient Wegmueller Monika |
Confidentiality: null Normal (qualifier value) (http://snomed.info/sct#17621005)
Sections:
Immunization Administration |
Resource Patient "TC-patient"
Profile: CH Core Patient EPR
identifier: Medical record number/12345678
name: Monika Wegmueller
telecom: ph: tel:+41.32.685.12.34(HOME)
gender: female
birthDate: 1967-02-10
address: Leidensweg 10 Specimendorf 9876 CH
Generated Narrative: Practitioner
Resource Practitioner "TC-HCP1-C1"
Profile: CH Core Practitioner EPR
identifier: GLN/7601888888884
active: true
name: Peter Müller
telecom: ph: tel:+41.32.234.55.66(WORK), fax: fax:+41.32.234.55.67(WORK), mailto:allzeit.bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch
address: Grabenstrasse 2 Zürich 8005 CH
Generated Narrative: Organization
Resource Organization "TC-ORG1"
Profile: CH Core Organization EPR
identifier: GLN/7601777777718
name: Gruppenpraxis Müller
telecom: ph: tel:+41.32.234.55.66(WORK), fax: fax:+41.32.234.55.67(WORK), mailto:bereit@gruppenpraxis.ch, http://www.gruppenpraxis.ch
address: Grabenstrasse 2 Zürich ZH 8005 CH
Generated Narrative: PractitionerRole
Resource PractitionerRole "TC-HCP1-ORG1-ROLE-performer"
Profile: CH Core PractitionerRole EPR
active: true
practitioner: See above (Practitioner/TC-HCP1-C1)
organization: See above (Organization/TC-ORG1)
Generated Narrative: Immunization
Resource Immunization "TCA01-IMMUN1-patient"
Profile: CH VACD Immunization
Author of the content: See above (Patient/TC-patient)
CH VACD Extension Immunization Medication Reference: See above (Medication/TC-IMMUN-MEDIC-HAVRIX1440)
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/acc1f090-5e0c-45ae-b283-521d57c3aa2f
status: completed
vaccineCode: Havrix 1440 (CH VACD Swissmedic Authorized Vaccines#558)
patient: See above (Patient/TC-patient)
occurrence: 2021-06-01
recorded: 2021-06-02 00:00:00+0200
lotNumber: AHAVB946A
route: Intramuscular use (standardterms.edqm.eu#20035000)
Actor |
See above (PractitionerRole/TC-HCP1-ORG1-ROLE-performer) |
note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-01)
TargetDisease | DoseNumber[x] |
Viral hepatitis, type A (disorder) (SNOMED CT#40468003) | 1 |
Generated Narrative: Medication
Resource Medication "TC-IMMUN-MEDIC-HAVRIX1440"
Profile: CH VACD Medication For Immunization
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/359000dc-2cee-4a6e-ab05-577f558840e2
code: HAVRIX 1440 Inj Susp (unknown#7680005580054)
status: active
manufacturer: See above (Organization/TC-ORG-GSK)
form: Suspension for injection (EDQM - Standard Terms#11202000)
amount: 1 milliliter (Details: UCUM code mL = 'mL')/1 Syringe (unit of presentation) (Details: SNOMED CT code 733020007 = 'Syringe')
Item[x] |
Immunologic substance (substance) (SNOMED CT#106181007) |
LotNumber |
AHAVB946A |
Generated Narrative: Organization
Resource Organization "TC-ORG-GSK"
Profile: CH Core Organization
identifier: GLN/7601001000674
name: GlaxoSmithKline AG
telecom: ph: tel:+41 31 862 21 11(WORK), fax: fax:+41 31 862 22 00(WORK), mailto:swiss.info@gsk.com, https://www.gsk.com
address: Talstrasse 3-5 Münchenbuchsee BE 3053 CH